RNA-seq is helping researchers take a fresh look at gene expression and its relationship to biological phenomena.
Illumina said today it will acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems (LIMS) for life science organizations, in a...
Many of the mutations that are found with tumor-only genetic sequencing are not actually tumor-related. Instead, they are just germline mutations, which are inherited...
DNAnexus taps the open-source variant calling tool on its cloud-based platform through a pilot program to serve its broad range of customers
To help identify disease-causing variants in the genome, researchers developed a tool that works by producing artificial “minigenes.”
The NIH plans to spend $42 million over five years to fund clinical trials designed to evaluate whether and how the management of diseases...
Initiative designed to encourage men with the disease in the U.S. and Canada to share their data with researchers studying the disease
The researchers from Chongqing Medical University in Chongqing, China, also found that people’s antibody response to SARS-CoV-2 may diminish rapidly after infection, which may have implications for the interpretation of negative serological results.
Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.
Tibsovo gains approval for adult patients with relapsed or refractory acute myeloid leukemia with specific mutations in the IDH1 gene